Sleep problems and magnesium levels in depression
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how sleep problems relate to magnesium levels in people with major depressive disorder. It may help understand the role of magnesium in sleep and depression, and could guide future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of major depressive disorder.
- You are 18 years of age or older.
- You can complete two questionnaires (BDI-II and PSQI) about mood and sleep.
- You are willing to participate and sign a consent form.
- You do not have chronic kidney failure or a metabolic disorder that affects magnesium.
- You do not currently take medications that significantly change magnesium levels (like long-term diuretics or proton pump inhibitors) unless stable and documented.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a workshop that teaches about premenstrual dysphoric disorder (PMDD) and sleep can help women and individuals with PMDD who also have sleep problems. It aims to improve sleep and overall well-being.
This study tests whether adding magnesium bisglycinate (a mineral supplement) to your current antidepressant medication can help improve depression symptoms. Researchers want to see if this combination works better than antidepressant alone.
This study tests whether taking a magnesium supplement at night can improve sleep quality in women who have mild sleep problems. You will wear a smart ring to track your sleep, and the study lasts for several weeks to see if magnesium helps.
This study looks at people with a current episode of major depression and measures sleep and daily body-clock patterns, along with other mental health symptoms. They may help researchers better understand how sleep and mood changes relate, which could improve future care.
This Phase 2 trial tests whether magnesium plus vitamin B6 can reduce depressive symptoms in people who are newly diagnosed with bipolar I disorder. It also checks for safety over a short, 4-week treatment period.
This study tests whether taking a daily magnesium supplement helps healthy adults feel more relaxed. It is a double-blind, placebo-controlled trial, meaning neither you nor the researchers will know if you are getting the supplement or a placebo (a pill with no active ingredient).
Hear when a new Depressive Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.